Combined modality treatment of locally advanced lung cancer

Tumori

Volumn 84, Issue 2, 1998, Pages 259-269

  Trovò, Mauro G ^a   Gigante, Marco ^a   Minatel, Emilio ^a   Gobitti, Carlo ^a   Franchin, Giovanni ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Chemotherapy; Combined modality; Lung cancer; Radiotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; PROCARBAZINE; SENAZOLE; TOPOTECAN; VINCRISTINE; VINDESINE;

CANCER SURVIVAL; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; META ANALYSIS; NOMENCLATURE; REVIEW; TREATMENT OUTCOME;

EID: 0031749816     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400227     Document Type: Review

References (81)

1. Alberti W., Niederle N., Budach V., Konietzko N., Sack H.: Prospective randomised study comparing immediate radiotherapy (RT), chemo plus radiotherapy (CT + RT) or delayed radiotherapy in non-small cell lung cancer: J. Cancer Res. Clin. Oncol., 116: 503, 1990.
2. Anderson G., Deeley T.Y. , Smith C., Jani J.: Comparison of radiotherapy alone and radiotherapy with chemotherapy using adriamycin and 5-fluorouracil in bronchogenic carcinoma. Thorax, 36: 190, 1981.
3. Ansari R., Tokars R., Fisher W., Pennington K., Mantrtavadi R., O'Connor T.: A phase III study of thoracic irradiation with or without concomitant cisplatin in locoregional unresectable non small cell lung cancer (NSCLC): a Hoosier oncology group (H.O.G.) [abstract]. Proc. ASCO, 10: 241, 1991.
4. Antonia S.J., Wagner H., Williams C., Alberts M., Hubbell D., Robinson L., Hilstro J., Ruckdeschel J.C.: Concurrent paclitaxel/cisplatin with thoracic radiation in patients with Stage IIIA/B non-small cell carcinoma of the lung. Semin. Oncol., 22: 34, 1995.
5. Arriagada R., Bertino J.R., Bleenhen N.M., Brodin O., Feld R., Goldie J.H., Hansen H.H., Inde D.C., Le Chevalier T., Souhami R.L. and the workshop participants: Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer. In: Treatment modalities in Lung Cancer. Antibiot. Chemother., 41: 232, 1988.
6. Arriagada R., Pignon J.P., Le Chevalier T.: Thoracic radiotherapy in small cell lung cancer: rationale for timing and fractionation. Lung, 5: 237, 1989.
7. Balzi D., Bidoli E., Franceschi S., Arniani S., Pisani P., Geddes M.: Estimates of cancer incidence and mortality in Italian Regions. A.I.R.T., 1990.
8. Begg A.C: Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int. J. Radiat. Oncol. Biol. Phys., 19: 1183, 1990.
9. Bellamy S., Hill B.T.: Interactions between clinically effective antitumor drugs and radiation in experimental systems. Biochem. Biophys. Acta, 738:125, 1984.
10. Bergsagel D.E., Phil D., Jenkin R.D.T.: Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer, 30: 621, 1972.
11. Birch R., Omura G. Greco F.M.: Patterns of failure in combined chemotherapy and radiotherapy for limited small-cell lung cancer. South Eastern Chemotherapy Group experience. Monogr. Natl. Cancer Inst., 6: 265, 1988.
12. Blanke C., Ansari R., Mantravadi R., Gonin R., Tokars R., Fischer W.: Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J. Clin. Oncol., 13: 1425, 1995.
13. Brodin O.: The Swedish Multicentre Group for the Study of Squamous Cell Carcinoma of the Lung. Patients with non-resectable squamous cell carcinoma of the lung. A prospective randomized study. Lung Cancer, 7: 165, 1991.
14. Bunn P.A. Jr, Lichter A.S., Makuch R.W.: Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective randomized trial. Ann. Intern. Med., 106: 655, 1987.
15. Cardiello C., Blanco Villalba J., Anac S., Francheri Wilson C., Trodler C., Hunis A.: Combined radiochemotherapy (RT-CT) versus radiotherapy (RT) in limited inoperable non-small cell carcinoma of the lung (NSCLC). Proc. ASCO, 4: C692, 1985.
16. Carlson R.W., Sikic B.I.: Late consolidative radiation therapy in the treatment of limited stage small cell lung cancer. Cancer, 68: 948, 1991.
17. Creech R., Richter M., Finkelstein D.: Combination chemotherapy with or without consolidation radiation therapy (RT) for regional small cell carcinoma of the lung [Abstract]. Proc. ASCO, 7: 196, 1989.
18. Crinò L., Latini P., Meacci M., Corgna E., Marazano E., Darwish S.: Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann. Oncol., 4: 51, 1993.
19. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L. Perry M.C.: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N. Engl. J. Med., 323: 940, 1990.
20. Edelstein M.P., Lawrence A.W.III, Duch D.S.: Potentiation of Radiation Therapy by Vinorelbine (Navelbine) in Non-small Cell Lung Cancer. Semin. Oncol., 23: 41, 1996.
21. Epstein R.J.: Drug-induced DNA damage and tumor chemosensitivity. J. Clin. Oncol., 8: 2062, 1990.
22. Fox R.M., Woods R.L., Brodie G.N., Tattersall M.H.N.: A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 6: 1083, 1980.
23. Fox W., Scadding J.G.: Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-cell or oat-cell carcinoma of the bronchus. Ten year follow-up. Lancet, 2 (820): 63, 1973.
24. Greco F.A., Perez C.; Einhorn L.H.: Combination chemotherapy with or without concurrent thoracic radiotherapy (RT) in limited-stage (LD) small cell lung cancer (SCLC): A phase III trial of the Southeastern Cancer Study Group (SEG) [Abstract]. Proc. ASCO, 5: 698, 1986.
25. Gregor A., Drings P., Burghouts J., Poostmus P.E., Morgan D., Sahmoud T., Kirkpatrick A., Dalesio O., Giaccone G.: Randomized Trial of Alternating Versus Sequential Radiotherapy/Chemotherapy in Limited-Disease Patients With Small-Cell Lung Cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J. Clin. Oncol., 15: 2840, 1997.
26. Gregor A., Macbeth F.R., Paul J., Cram L., Hansen H.H.: Radical radiotherapy in localized inoperable non-small cell lung cancer: a randomized trial. J. Natl. Cancer Inst., 85: 997, 1993.
27. Host H.: Cyclophosphamide (NSC-26271d) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic car-cinoma. Cancer Chemother. Rep., 4: 161, 1973.
28. Israel L., Depiere A., Dalesio O.: Interim results of EORTC protocol 08742: comparison, after irradiation of locally advanced squamous cell bronchial carcinoma, immunotherapy, combination chemotherapy, or chemoimmunotherapy. Rec. Res. Cancer Res., 80: 214, 1982.
29. Jensen O.M., Esteve J., Moller H., Renard H.: Cancer in the European Community and its Members States. Eur. J. Cancer, 26: 1167, 1990.
30. Jeremic B., Shibamoto Y., Acimovic K., Djuric L.: Randomized trial of Hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J. Clin. Oncol., 13: 452, 1995.
31. Johnson D.H., Einhorn L.H., Bartolucci A., Birch R., Omura G., Perez C.A.: Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann. Intern. Med., 113: 33, 1990.
32. Joss R., Alberto P., Bleher E., Ludwig C., Siegenthaler P., Martinelli G., Sauter C., Schatzmann E., Senn H.J.: Combined-modality treatment of small cell lung cancer (SCLC): randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy (RT) to the chest. Ann. Oncol., 5:921,1994.
33. Kanzawa F., Saijo N.: In Vitro Interaction Between Gemcitabine and Other Anticancer Drugs Using a Novel Three-Dimensional Model. Semin. Oncol., 24 (suppl. 7): 8, 1997.
34. Kies M.S., Mira J.C., Livingston R.B.: Multimodal therapy for limited small cell lung cancer. A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders and with widefield versus reduced volume radiation in partial responders. J. Clin. Oncol., 5: 592, 1987.
35. Lawrence T.S., Eisbruch A., Shewach D.S.: Gemcitabine-Mediated Radiosensitization. Semin. Oncol., 24 (suppl 7): 7, 1997.
36. Le Chevallier T., Arriagada R., Quoix E., Ruffle P., Martin V., Tarayre M.: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. J. Natl. Cancer Inst., 83: 417, 1991.
37. Lebeau B., Chastang C., Brèchot J.M.: Small cell lung cancer (SCLC): negative results of a randomized clinical trial on delayed thoracic radiotherapy administered to complete responders (CR) patients. Lung Cancer, 7: 94, 1991.
38. Marino P., Preatoni A., Cantoni A.: Randomized Trials of radiotherapy Alone versus Combined Chemotherapy and Radiotherapy in Stages IIIa and Radiotherapy in Stages IIIa and IIIb Nonsmall Cell Lung Cancer. Cancer, 76: 593, 1995.
39. Mattson K., Holsti L.R., Holsti P., Jakobsson M., Kajanti M., Liippo K.: Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur. J. Cancer, 24: 477, 1988.
40. McGinnis W.L., Shaw E.G., Jung S.H., Jett J., Stella P., Marschke R.: Results of a phase III prospective randomized trial comparing standard thoracic radiation therapy to twice-delay RT +/- concomitant etoposide-cisplatine chemotherapy in patients with unresectable stage IIIA/B non-small-cell lung cancer [abstract]. Proc. ASCO, 14: 355, 1995.
41. Medical Research Council Lung Cancer Working Party. Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung: the results at 36 months. Br. J. Cancer., 44: 611, 1981.
42. Morton R.F., Jett J.R., McJinnis, W.L., Earle J.D., Therneau T.M. Krook J.E.: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. Ann. Intern. Med., 115: 681, 1991.
43. Murray N., Shah A., Brown E.: Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small cell carcinoma of the lung. Semin. Oncol., 13: 24, 1986.
44. Nou E., Brodin O., Bergh J.: A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens. Cancer., 62: 1079, 1988.
45. Ohnoshi T., Hiraki S., Kawahara S.: Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report. Jap. J. Clin. Oncol., 16: 271, 1986.
46. Osterlind K., Hansen H.H., Hansen H.S., Dombernowsky P., Hansen M., Rorth M.: Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up. Br. J. Cancer, 54: 7, 1986.
47. Parker S.L., Tong T., Bolden S.: Cancer statistics. Ca-Cancer J. Clin., 65: 5, 1996.
48. Pavy J.J., Denekamp J., Letschert J., Littbrand B., Mornex F., Bernier J.: Late effects toxicity scoring: the SOMA scale. Int. J. Radiat. Oncol. Biol. Phys., 31: 1043, 1995.
49. Payne D., Arrigada R., Dombernowsky P.: The role of thoracic radiation therapy in small cell carcinoma of the lung: a consensus report. Lung Cancer, 5: 135, 1989.
50. Perez C.A., Einhorn L., Oldham R.K.: Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. J. Clin. Oncol., 2: 1200, 1984.
51. Perry M.C., Eaton W.L., Propert K.J.: Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N. Eng. J. Med., 316: 912, 1987.
52. Pignon J.P., Arriagada R., Ihde D.C., Johnson D.J., Perry M.C., Souhami R.L., Brodin O., Joss R.A., Kies M.S., Lebeau B., Onoshi T., Osterlind K., Tattersall M.H.N., Wagner H. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N. Engl. J. Med., 327: 1618, 1992.
53. Pritchard R.S., Anthony S.P.: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. Ann. Int. Med., 125: 723, 1996.
54. Robert J., Mornex F.: Radiothérapie et chimiothérapie concomitante des cancers. Aspects pharmacologiques. Bull. Cancer Radiother., 80: 331, 1993.
55. Rosenthal M.A., Tattersall M.H.N., Fox R.M., Woods R.L., Brodie G.N.: Adjuvant thoracic radiotherapy in small cell lung cancer: ten-year follow-up of a randomized study (Sidney trial) Lung Cancer, 7: 235, 1991.
56. Sause W., Scott C., Byhardt R.: Recursive partitioning analysis of 1592 patients on four RTOG studies in non-small-cell lung cancer. Proc. ASCO, 12: 336, 1993.
57. Sause W., Scott C., Taylor S., Johnson D., Livingston D., Komaki R.: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J. Natl. Cancer Inst., 87: 198, 1995.
58. Sause W.T.: Non Small Cell Lung Cancer. Proc. ASTRO, 310: 1-22, 1997.
59. Schallier D.C., De Neve W.J., De Greve J.L., Van Belle S.P., De Wasch G.J., Dotremont G.: Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous cell lung cancer? A randomized study. Clin. Exp. Metastas., 6: 39, 1988.
60. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P.: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N. Engl. J. Med., 326: 524, 1992.
61. Sidorowitz E., Dhirsch V., Hand R., Guerra J., Margolese R., Thirlwell M.: Comparison of radiotherapy (RT) and RT-MACC chemotherapy in limited non-small cell lung cancer (NSCLC). Proc. of the fourth world conference on lung cancer, Toronto: A277, 1985.
62. Simpson J.R., Francis M.E., Perez-Tamayo R. Marks R.D., Rao D.V.: Palliative radiotherapy for inoperable carcinoma of the lung: final report of an RTOG multi-institutional trial. Int. J. Radiat. Oncol. Biol. Phys., 11: 751, 1985.
63. Soresi E., Clerici M., Grilli R., Borghini R., Zucali R., Leoni M., Bottrui M., Vergari C., Luporini G., Scoccia S.: A Randomized Clinical Trial Comparing Radiation Therapy Plus cis-Dichlorodiammine Platinum (II) in the Treatment of Locally Advanced Non-Small Cell Lung Cancer. Semin. Oncol., 15: 20, 1988.
64. Souhami R.L., Geddes D.M., Spiro S.G.: Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. B. M. J., 288: 1643, 1984.
65. Steel G.G., Peckham M.U.: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys., 5: 85, 1979.
66. Steel G.G.: Combination of radiotherapy and chemotherapy. principles. In: Basic Clinical Radiobiology, second edition, Steel G.G. (ed.), p. 184, Arnold, London, 1997.
67. Steel G.G.: The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother. Oncol., 1: 31, 1988.
68. Stevens E., Einhorn L., John R.: Treatment of limited small cell cancer. Proc. Am. Assoc. Cancer Res., 20: 599, 1979.
69. Stewart L.A., Pignon J.P.: (Non -small Cell Cancer Collaborative Group). Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. B. M. J., 311: 899, 1995.
70. Tannock I.F., Rotin D.: Keynote Address: Mechanisms of Interaction Between Radiation and Drugs With Potential for Improvements in Therapy. NCI Monographs, 6: 77, 1988.
71. Trovò M.G., Minatel E., Franchin G.: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 24: 11, 1992.
72. Trovò M.G., Minatel E., Veronesi A., Roncadin M., De Paoli A., Franchin G.: Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma (a randomised study). Cancer, 65: 400, 1990.
73. Tubiana M.: The combination of radiotherapy and chemotherapy. A review. Int. J. Radiat. Biol. 55: 597, 1989.
74. Van Houtte P., Klastersky J., Renaud A., Michel J., Vandermoten G., Nguyen H.: Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for non-small cell lung cancer. Treatment modalities in lung cancer. Antibiot. Chemother., 41: 131, 1988.
75. Vokes E.E., Weichselbaum R.R.: Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J. Clin. Oncol., 8: 911, 1990.
76. Warde P., Payne D.: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J. Clin. Oncol., 10: 890, 1992.
77. White J.E., Chen T., Reed R., Mira J., Stuckey W.J., Weatherall T: Limited squamous cell carcinoma of the lung: a South-west Oncology Group randomised study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. Cancer Treat. Rep., 66: 1113, 1982.
78. Wils J.A., Utama I., Naus A, Verschueren T.A.: Phase II randomized trial of radiotherapy alone vs the sequential use of chemotherapy and radiotherapy in stage III non-small cell lung cancer: Phase II trial of chemotherapy alone in stage IV non-small cell lung cancer. Eur. J. Cancer, 20: 911, 1984.
79. Wolf M., Hans K., Becker H., Hassler R., von Bultzingslowen F, Goerg R.: Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin. Oncol., 21: 42, 1994.
80. Work E., Nielsen O.S., Bentzen S.M, Fode K.: Palshof T, for the Aarhus Lung Cancer Group: Randomized study of initial versus late chest irradiation combined with chemotherapy in limited stage small-cell lung cancer. J. Clin. Oncol., 15: 3030, 1997.
81. Zanelli G.D., Quaia M., Robieux I., Bujor L., Santarosa M., Favaro D., Spada A., Caffau C., Gobitti C., Trovò M.G.: Paclitaxel as a Radiosensitiser: A Proposed Schedule of Administration Based on In Vitro Data and Pharmacokinetic Calculations. Eur. J.Cancer., 33: 486, 1997.